Emergent Biosolutions Inc (United States) is listed on the Nasdaq and has a market capitalization of $242.58 million, with shareholders equity totaling $341.40 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Emergent Biosolutions Inc reported $742.30 million in revenue, generating net income of $-176.80 million.
Key financial metrics include a P/E ratio of -1.37, a price-to-book (P/B) ratio of 0.71, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker EBS.